Cite
HARVARD Citation
Khan, J. et al. (2016). Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study. Journal of the American Heart Association. 5 (6), p. n/a. [Online].